← Back
Data updated: Mar 10, 2026
STERIMAX
CardiovascularRespiratory
STERIMAX is a specialty pharmaceutical company focused on Cardiovascular, Respiratory.
1981
Since
4
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Respiratory 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 1981-03-11
- Latest
- 2020-06-09
- Applications
- 3